Li-Cycle Holdings Analyst Ratings
Li-Cycle Holdings Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 68.07% | Wedbush | → $8 | Reiterates | Outperform → Outperform |
| 08/01/2023 | 68.07% | Chardan Capital | → $8 | Reiterates | Buy → Buy |
| 06/26/2023 | 47.06% | Piper Sandler | $10 → $7 | Maintains | Overweight |
| 05/16/2023 | 68.07% | Chardan Capital | → $8 | Reiterates | Buy → Buy |
| 05/04/2023 | 78.57% | Cantor Fitzgerald | → $8.5 | Initiates Coverage On | → Buy |
| 05/03/2023 | 68.07% | Chardan Capital | $10 → $8 | Maintains | Buy |
| 03/31/2023 | 68.07% | TD Securities | $10 → $8 | Maintains | Outperform |
| 03/31/2023 | 68.07% | Baird | $7 → $8 | Maintains | Neutral |
| 02/28/2023 | 110.08% | Chardan Capital | → $10 | Reiterates | → Buy |
| 02/01/2023 | 47.06% | Citigroup | $7.5 → $7 | Maintains | Buy |
| 01/31/2023 | 110.08% | Chardan Capital | $13 → $10 | Maintains | Buy |
| 01/31/2023 | 47.06% | Baird | $8 → $7 | Maintains | Neutral |
| 01/25/2023 | -15.97% | Morgan Stanley | $7 → $4 | Downgrades | Equal-Weight → Underweight |
| 12/15/2022 | 57.56% | Citigroup | $8 → $7.5 | Maintains | Buy |
| 09/30/2022 | 47.06% | Morgan Stanley | $8 → $7 | Maintains | Equal-Weight |
| 09/15/2022 | 173.11% | Chardan Capital | $18 → $13 | Maintains | Buy |
| 09/15/2022 | 68.07% | Baird | $11 → $8 | Maintains | Neutral |
| 09/15/2022 | 110.08% | BMO Capital | $12 → $10 | Maintains | Outperform |
| 06/15/2022 | 110.08% | Cowen & Co. | $14 → $10 | Maintains | Outperform |
| 06/15/2022 | 131.09% | Baird | $9 → $11 | Maintains | Neutral |
| 06/03/2022 | 68.07% | Morgan Stanley | $10 → $8 | Maintains | Equal-Weight |
| 04/07/2022 | 110.08% | Citigroup | $11 → $10 | Maintains | Buy |
| 02/10/2022 | 110.08% | Morgan Stanley | → $10 | Downgrades | Overweight → Equal-Weight |
| 01/13/2022 | 278.15% | Chardan Capital | $17 → $18 | Maintains | Buy |
| 11/23/2021 | 257.14% | Chardan Capital | → $17 | Initiates Coverage On | → Buy |
| 09/22/2021 | 215.13% | UBS | → $15 | Initiates Coverage On | → Buy |
| 09/20/2021 | 194.12% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
| 09/14/2021 | 215.13% | Morgan Stanley | → $15 | Initiates Coverage On | → Overweight |
| 09/10/2021 | 173.11% | BMO Capital | → $13 | Initiates Coverage On | → Outperform |
| 08/23/2021 | 131.09% | Baird | → $11 | Initiates Coverage On | → Neutral |
| 08/23/2021 | 215.13% | Cowen & Co. | → $15 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年08月15日 | 68.07% | 韦德布什 | →$8 | 重申 | 跑赢→跑赢大盘 |
| 08/01/2023 | 68.07% | 查尔丹资本 | →$8 | 重申 | 购买→购买 |
| 2023/06/26 | 47.06% | 派珀·桑德勒 | $10→$7 | 维护 | 超重 |
| 2023年05月16日 | 68.07% | 查尔丹资本 | →$8 | 重申 | 购买→购买 |
| 05/04/2023 | 78.57% | 康托·菲茨杰拉德 | →$8.5 | 开始承保 | →购买 |
| 05/03/2023 | 68.07% | 查尔丹资本 | $10→$8 | 维护 | 买 |
| 03/31/2023 | 68.07% | 道明证券 | $10→$8 | 维护 | 跑赢大盘 |
| 03/31/2023 | 68.07% | 贝尔德 | $7→$8 | 维护 | 中性 |
| 02/28/2023 | 110.08% | 查尔丹资本 | →$10 | 重申 | →购买 |
| 02/01/2023 | 47.06% | 花旗集团 | $7.5→$7 | 维护 | 买 |
| 2023年1月31日 | 110.08% | 查尔丹资本 | $13→$10 | 维护 | 买 |
| 2023年1月31日 | 47.06% | 贝尔德 | $8→$7 | 维护 | 中性 |
| 2023年1月25日 | -15.97% | 摩根士丹利 | $7→$4 | 评级下调 | 等重→减码 |
| 2022年12月15日 | 57.56% | 花旗集团 | $8→$7.5 | 维护 | 买 |
| 09/30/2022 | 47.06% | 摩根士丹利 | $8→$7 | 维护 | 等重 |
| 09/15/2022 | 173.11% | 查尔丹资本 | $18→$13 | 维护 | 买 |
| 09/15/2022 | 68.07% | 贝尔德 | $11→$8 | 维护 | 中性 |
| 09/15/2022 | 110.08% | 蒙特利尔银行资本 | $12→$10 | 维护 | 跑赢大盘 |
| 2022/06/15 | 110.08% | 考恩公司 | $14→$10 | 维护 | 跑赢大盘 |
| 2022/06/15 | 131.09% | 贝尔德 | $9→$11 | 维护 | 中性 |
| 06/03/2022 | 68.07% | 摩根士丹利 | $10→$8 | 维护 | 等重 |
| 04/07/2022 | 110.08% | 花旗集团 | $11→$10 | 维护 | 买 |
| 02/10/2022 | 110.08% | 摩根士丹利 | →$10 | 评级下调 | 超重→等重 |
| 2022年01月13日 | 278.15% | 查尔丹资本 | $17→$18 | 维护 | 买 |
| 2021年11月23日 | 257.14% | 查尔丹资本 | →$17 | 开始承保 | →购买 |
| 09/22/2021 | 215.13% | 瑞银集团 | →$15 | 开始承保 | →购买 |
| 09/20/2021 | 194.12% | 韦德布什 | →$14 | 开始承保 | →跑赢大盘 |
| 09/14/2021 | 215.13% | 摩根士丹利 | →$15 | 开始承保 | →超重 |
| 09/10/2021 | 173.11% | 蒙特利尔银行资本 | →$13 | 开始承保 | →跑赢大盘 |
| 2021/08/23 | 131.09% | 贝尔德 | →$11 | 开始承保 | →中性 |
| 2021/08/23 | 215.13% | 考恩公司 | →$15 | 开始承保 | →跑赢大盘 |
What is the target price for Li-Cycle Holdings (LICY)?
Li周期控股(利好)的目标价是多少？
The latest price target for Li-Cycle Holdings (NYSE: LICY) was reported by Wedbush on August 15, 2023. The analyst firm set a price target for $8.00 expecting LICY to rise to within 12 months (a possible 68.07% upside). 18 analyst firms have reported ratings in the last year.
韦德布什于2023年8月15日报道了Li周期控股(纽约证券交易所代码：LICE)的最新目标价。这家分析公司将目标价定为8.00美元，预计里奇将在12个月内上涨(可能上涨68.07%)。去年有18家分析公司公布了评级。
What is the most recent analyst rating for Li-Cycle Holdings (LICY)?
分析师对Li周期控股(LICY)的最新评级是多少？
The latest analyst rating for Li-Cycle Holdings (NYSE: LICY) was provided by Wedbush, and Li-Cycle Holdings reiterated their outperform rating.
对Li周期控股(纽约证券交易所代码：LICE)的最新分析师评级由韦德布什提供，Li周期控股重申其表现优于大盘的评级。
When is the next analyst rating going to be posted or updated for Li-Cycle Holdings (LICY)?
Li周期控股(LICY)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Li-Cycle Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Li-Cycle Holdings was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析师在进行了广泛的研究后得出了股票评级，这些研究包括查阅公开的财务报表，与Li周期控股的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Li周期控股的上一次评级是在2023年8月15日提交的，因此你应该预计下一次评级将在2024年8月15日左右公布。
Is the Analyst Rating Li-Cycle Holdings (LICY) correct?
分析师对Li周期控股(LICY)的评级正确吗？
While ratings are subjective and will change, the latest Li-Cycle Holdings (LICY) rating was a reiterated with a price target of $0.00 to $8.00. The current price Li-Cycle Holdings (LICY) is trading at is $4.76, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Li周期控股(LICY)评级被重申，目标价在0.00美元至8.00美元之间。Li周期控股目前的股价为4.76美元，在分析师的预测范围内。